Solventum Co. (NYSE:SOLV) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Solventum Co. (NYSE:SOLV) have been given a consensus recommendation of “Hold” by the eleven ratings firms that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $68.29.

A number of research firms have commented on SOLV. Wolfe Research began coverage on shares of Solventum in a report on Thursday, September 26th. They set a “peer perform” rating for the company. Stifel Nicolaus started coverage on Solventum in a research report on Tuesday, October 8th. They set a “buy” rating and a $82.00 target price for the company. Mizuho assumed coverage on shares of Solventum in a research report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price target on the stock. Morgan Stanley upped their price objective on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. Finally, BTIG Research assumed coverage on Solventum in a research report on Thursday, September 5th. They issued a “neutral” rating for the company.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Copeland Capital Management LLC bought a new position in shares of Solventum in the third quarter worth $26,000. Mather Group LLC. bought a new position in Solventum in the 3rd quarter valued at approximately $27,000. Hollencrest Capital Management acquired a new position in Solventum in the 2nd quarter valued at approximately $25,000. True Wealth Design LLC raised its position in Solventum by 23,550.0% during the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after purchasing an additional 471 shares during the last quarter. Finally, Deseret Mutual Benefit Administrators acquired a new stake in shares of Solventum during the second quarter worth $25,000.

Solventum Stock Down 0.6 %

Shares of NYSE:SOLV opened at $69.56 on Monday. The business has a fifty day moving average of $70.91 and a 200-day moving average of $63.24. Solventum has a twelve month low of $47.16 and a twelve month high of $96.05. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.